Benjamin Chien
Chairman, President and CEO
Oncology
QPS
United States of America
Biography
Dr. Benjamin Chien, also known as Ben, Ph.D. Founded Foresee Pharmaceuticals Co., Ltd. and serves as its Chairman. Dr. Chien served as Chief Executive Officer of Foresee Pharmaceuticals Co., Ltd. until August 1, 2017. Dr. Chien founded QPS Holdings, LLC in 1995 and serves as its Chairman of the Board, Chief Executive Officer and President. Dr. Chien serves as the Chief Executive Officer and President at QPS, L.L.C. Dr. Chien is the Co-Inventor of a novel Ion Trap/Time-of-Flight Mass Spectrometer. He started his pharmaceutical career at DuPont Merck Pharmaceutical Co. in the Drug Metabolism and Pharmacokinetics Section, where he built the LC/MS/MS group dedicated to supporting drug discovery, preclinical and clinical studies. In 1996, he received the Summit Award, the highest level of achievement at DuPont Merck for his dedicated contribution to the development of Efavirenz, an anti-viral drug approved by the FDA for the treatment of HIV disease. Under his guidance, QPS is recognized as a premier DMPK laboratory. He is a consultant for a number of pharmaceutical and biotechnology companies. Dr. Chien obtained Ph.D. in analytical chemistry (mass spectrometry) from the University of Michigan at Ann Arbor.
Research Interest
Cancer Healthy Futures Scare resources Transforming Industry Transforming Socities